Abstract:Abstract Background Growth factors (GFs) are signaling proteins that affect cellular processes such as growth, proliferation, and differentiation. GFs are used as cosmeceuticals, exerting anti-wrinkle, anti-aging, and whitening effects, and also as pharmaceuticals to treat wounds, growth failure, and oral mucositis. However, in mammalian and bacterial cells, low productivity and expression in inclusion bodies, respectively, of GFs does not satisfy the consumer demand. Here, we aimed to develop a bacterial expression system that produces high yields of soluble GFs that can be purified in their native forms. Results We present Fh8, an 8-kDa peptide from Fasciola hepatica with an N-terminal hexa-histidine (6HFh8), as a fusion partner for enhanced human GF production in recombinant Escherichia coli . The fusion partner harboring a tobacco etch virus (TEV) protease cleavage site was fused to the N-terminus of 10 human GFs: acidic and basic fibroblast growth factors (aFGF and bFGF, respectively), epidermal growth factor (EGF), human growth hormone (hGH), insulin-like growth factor 1 (IGF-1), vascular endothelial growth factor 165 (VEGF165), keratinocyte growth factor 1 (KGF-1), placental growth factor (PGF), stem cell factor (SCF), and tissue inhibitor of metalloproteinase 1 (TIMP-1). The fusion proteins were expressed in E. coli under the control of T7 promoter at three temperatures (25 °C, 30 °C, and 37 °C). All individual fusion proteins, except for SCF and TIMP-1, were successfully overexpressed in cytoplasmic soluble form at more than one temperature. Further, the original aFGF, IGF-1, EGF, and VEGF165 proteins were cleaved from the fusion partner by TEV protease. Five-liter fed-batch fermentation approaches for the 6HFh8-aFGF (lacking disulfide bonds) and 6HFh8-VEGF165 (a cysteine-rich protein) were devised to obtain the target protein at concentrations of 9.7 g/l and 3.4 g/l, respectively. The two GFs were successfully highly purified (> 99% purity). Furthermore, they exerted similar cell proliferative effects as those of their commercial equivalents. Conclusions We demonstrated that 6HFh8-GF fusion proteins could be overexpressed on a g/l scale in the cytoplasm of E. coli , with the GFs subsequently highly purified and maintaining their biological activity. Hence, the small protein 6HFh8 can be used for efficient mass-production of various GFs.

Enhanced plasmid stability and production of hEGF by immobilized recombinant E. coli JM101

Human fibroblast matrices bio-assembled under macromolecular crowding support stable propagation of human embryonic stem cells.

Effect of Polyethyleinimine on Properties of Immobilized Growth Cells

A novel two-stage continuous process for excretive expression of hEGF by recombinant E. coli JM101

Economic optimization of expression of soluble human epidermal growth factor in Escherichia coli

A pH-induced, intein-mediated expression and purification of recombinant human epidermal growth factor in Escherichia coli

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

Hyperporous encapsulation of microbes for whole cell biocatalysis and biomanufacturing

Immobilization of growing cells by polyethyleneimine-modified alginate

[Enhancing the Expression Level of Human Epidermal Growth Factor Using the Polyhedrin Protein Sequence of BmNPV].

Optimization of Secreted Recombinant Human Epidermal Growth Factor Production Using Pectate Lyase B from Escherichia Coli BL21(DE3) by Central Composite Design and Its Production in High Cell Density Culture

Optimization of the Fermentation Conditions of Pep-1-Fused EGF in Escherichia coli

Production of recombinant human epidermal growth factor in Pichia pastoris

Large-Scale Preparation of Highly Stable Recombinant Human Acidic Fibroblast Growth Factor in Escherichia coli BL21(DE3) plysS Strain

Effective production of human growth factors in Escherichia coli by fusing with small protein 6HFh8

Scaling up production of recombinant human basic fibroblast growth factor in an Escherichia coli BL21(DE3) plysS strain and evaluation of its pro-wound healing efficacy

Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli

In Situ Immobilization of Proteins and Rgd Peptide on Polyurethane Surfaces Via Poly(Ethylene Oxide) Coupling Polymers for Human Endothelial Cell Growth

The Effective Astaxanthin Productivities of Immobilized Haematococcus Pluvialis with Bacterial Cellulose

Peptides-modified polystyrene-based polymers as high-performance substrates for the growth and propagation of human embryonic stem cells

Highly efficient soluble expression and purification of recombinant human basic fibroblast growth factor (hbFGF) by fusion with a new collagen-like protein (Scl2) in Escherichia coli